Top Markets
#1 PulseChain PulseChain +43.68%
#2 Bitway Bitway +9.64%
#3 Meteora Meteora +8.38%
#4 Velvet Velvet +7.60%
#5 Not in Employment, Education, or Training Not in Employment, Education, or Training +7.15%
#6 eCash eCash +6.72%
#7 Fake World Assets Fake World Assets +6.06%
#8 Bitcoin SV Bitcoin SV +5.96%
#9 Cash Cat Cash Cat +5.45%
#10 Rocket Pool Rocket Pool +5.30%
Coin of the day
PulseChain PulseChain
Ayarlar
Dil
TüRKçE
Para birimi
USD
Tema
Resverlogix Corp. Resverlogix Corp.

Resverlogix Corp.

RVX
Hisse Senetlerindeki Sıralama #28673
Resverlogix Corporation is a biotechnology firm currently in advanced clinical... Resverlogix Corporation is a biotechnology firm currently in advanced clinical development, concentrating on developing treatments for illnesses where existing medical solutions are inadequate. The company's leading therapeutic compound is apabetalone (RVX-208), a selective small molecule designed to inhibit bromodomain and extra-terminal proteins. This compound is presently undergoing pivotal Phase III clinical trials for patients afflicted with conditions such as cardiovascular disease, diabetes, various stages of kidney disease (including end-stage renal disease), and neurodegenerative disorders. Furthermore, Resverlogix Corp. has forged an alliance with Eversana Life Science Services, LLC to support the forthcoming commercial rollout of apabetalone as a treatment for COVID-19 across the United States and Canada. The company's main office is located in Calgary, Canada.
Hisse Fiyatı
$0.07339369
Son senkronizasyon: 2026-08-18
Piyasa Değeri
$25.24M
Değişim (1 gün)
5.26%
Değişim (1 yıl)
-7.44%
Ülke
CA
Ticaret Resverlogix Corp. (RVX)

Kategori

Healthcare
Resverlogix Corp. (RVX) için kazanç
2026 itibarıyla kazanç TTM: 0
Resverlogix Corp. şirketinin en son finansal raporlarına göre, mevcut kazancı 0'dir. 2026 yılında şirket 0 kazanç elde etti, bu 2026 yılındaki 0 kazanca göre önceki yıla eşit. Bu sayfada gösterilen kazanç, faiz ve vergiler öncesi kazançtır; yani EBIT.
Resverlogix Corp. için kazanç geçmişi 2026 - 2026
Her yılın sonundaki kazanç
Yıl Kazanç Değiştir
Sağlanan tarihler için yeterli veri yok.
Benzer şirketler veya rakipler için kazanç
Şirket Kazanç Kazanç Farkı Ülke
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
$-3.09B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
$1.61B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH